Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CECILE: Duodopa vs BMT in Advanced Parkinson's
NCT01291537Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- Nov 2011
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa in Parkinson's disease (PD), sponsored by CHU de Poitiers. Started Nov 2011; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01291537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291537.